# Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

> **NCT01166737** · NA · COMPLETED · sponsor: **AGO Study Group** · enrollment: 408 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **PROCEDURE:** Tumor Debulking Surgery (surgery in recurrent ovarian disease)

## Key facts

- **NCT ID:** NCT01166737
- **Lead sponsor:** AGO Study Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2020-01-17
- **Final completion:** 2020-12-31
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166737, "Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01166737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*